Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study
Table 2
Prevalence of statin and angiotensin-converting enzyme inhibitor (ACEI)/ angiotensin II receptor blocker (ARB) users in the pneumonia and control groups.